K41 Stock Overview
Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Scandinavian Medical Solutions A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 0.79 |
| 52 Week High | DKK 1.55 |
| 52 Week Low | DKK 0.76 |
| Beta | 0.41 |
| 11 Month Change | -13.76% |
| 3 Month Change | -21.78% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 31.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| K41 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -2.9% | -0.5% | -0.1% |
| 1Y | n/a | -2.1% | 2.3% |
Return vs Industry: Insufficient data to determine how K41 performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how K41 performed against the German Market.
Price Volatility
| K41 volatility | |
|---|---|
| K41 Average Weekly Movement | 4.9% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: K41's share price has been volatile over the past 3 months.
Volatility Over Time: K41's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 25 | Jens Paulsen | www.scandinavian-medical.com |
Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide. It offers equipment in the categories of CATH lab, CT, linear accelerator, mammography, PET/CT, SPECT/CT, X-ray, ultrasound, MRI, Gamma/SPECT, C-arm, mobile X-ray, R/F, and others, as well as provides CT, MRI, CATH lab, X-ray, MAMMO, PET/CT, and C-arm parts. The company also provides equipment rental and technical services.
Scandinavian Medical Solutions A/S Fundamentals Summary
| K41 fundamental statistics | |
|---|---|
| Market cap | €23.97m |
| Earnings (TTM) | €720.24k |
| Revenue (TTM) | €26.48m |
33.3x
P/E Ratio0.9x
P/S RatioIs K41 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| K41 income statement (TTM) | |
|---|---|
| Revenue | DKK 197.51m |
| Cost of Revenue | DKK 166.38m |
| Gross Profit | DKK 31.14m |
| Other Expenses | DKK 25.77m |
| Earnings | DKK 5.37m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 15.77% |
| Net Profit Margin | 2.72% |
| Debt/Equity Ratio | 27.7% |
How did K41 perform over the long term?
See historical performance and comparison